국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
erythromycin ethyl succinate
Amdipharm Mercury Australia Pty Ltd
Registered
EES ™ _200 MG/5 ML GRANULES; 400 MG/5 ML GRANULES_ _erythromycin as ethyl succinate_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about EES. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking EES against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT EES IS USED FOR EES is used to: • treat certain bacterial infections; these infections may occur in different parts of the body • control acne • prevent infections in patients with a history of rheumatic disease, congenital heart disease or other acquired valvular heart disease and who may be allergic to penicillin antibiotics. Your doctor, however, may have prescribed EES for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY EES HAS BEEN PRESCRIBED FOR YOU. EES is an antibiotic that belongs to the group of medicines called macrolides. These medicines work by killing or stopping the growth of bacteria, which cause infections or make acne worse. EES will not work against infections caused by viruses, such as colds or flu. EES is available only with a doctor's prescription. BEFORE YOU TAKE EES _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE EES IF YOU HAVE AN ALLERGY TO: • any medicine containing erythromycin • any of the ingredients listed at the end of this leaflet • other antibiotics from the macrolide family, including: - clarithromycin - roxithromycin. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. YOU MUST NOT TAKE EES IF: • you are taking - terfenadine or astemizole - cisapride, pimozide or dompe 전체 문서 읽기
EES ® 1 AUSTRALIAN PRODUCT INFORMATION EES ® ERYTHROMYCIN AS ETHYL SUCCINATE GRANULES FOR ORAL LIQUID 1 NAME OF THE MEDICINE Erythromycin ethyl succinate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION EES granules are available for oral administration in a strength of 200 mg erythromycin (as ethyl succinate) per 5 mL and 400 mg erythromycin (as ethyl succinate) per 5 mL once reconstituted. Erythromycin is produced by a strain of _Streptomyces erythraeus_ and belongs to the macrolide group of antibiotics. It is basic and readily forms salts with acids. The base, the stearate salt, and the esters are poorly soluble in water. EES products contain the ethyl succinate ester of erythromycin. Excipients with known effect: sucrose and saccharin sodium For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM EES 200 MG/5 ML GRANULES Pink free flowing granules. When reconstituted with water to make 100 mL of 200 mg (erythromycin) per 5 mL, pink opaque cherry flavoured suspension. EES 400 MG/5 ML GRANULES Pink free flowing granules. When reconstituted with water to make 100 mL of 400 mg (erythromycin) per 5 mL, pink opaque cherry flavoured suspension. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _STREPTOCOCCUS PYOGENES _(GROUP A BETA-HAEMOLYTIC STREPTOCOCCUS):_ _ Upper and lower respiratory tract, skin and soft tissue infections of mild to moderate severity. When oral medication is preferred for treatment of the above conditions, penicillin G, V, or erythromycin are alternate drugs of choice. EES ® 2 When oral medication is given, the importance of strict adherence by the patient to the prescribed dosage regimen must be stressed. A therapeutic dose should be administered for at least 10 days. ALPHA-HAEMOLYTIC STREPTOCOCCI (VIRIDANS GROUP): Although no controlled clinical efficacy trials have been conducted, oral erythromycin has been suggested by the American Heart Association and the American Dental Association for use in a regimen for prophylaxis against bacterial endocarditis in pat 전체 문서 읽기